Pledge Therapeutics (Private limited company)
Pledge Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0726.743.301. It was founded on 14-05-2019. Its registered office is in Leuven. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € -3 797 155 and a loss of € 1 400 905. These accounts report 6.6 full-time equivalents. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 0 of its last 4 financial years.
Information last updated on 18-10-2026.
Company information
Key figures of Pledge Therapeutics
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -1 400 905-103 % | € -688 788-23 % | € -558 654-37 % | € -408 469 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -3 797 155-58 % | € -2 396 250-40 % | € -1 707 462-49 % | € -1 148 807 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 229 854-21 % | € 292 422-19 % | € 361 319+5 % | € 344 183 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -644 682-561 % | € -97 474+32 % | € -144 155-62 % | € -88 925 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 6.6+12 % | 5.9+44 % | 4.1+17 % | 3.5 |
Financial estimate
Similar companies
Other companies in the same activity in Leuven.
| Company | Town |
|---|---|
| SOUND & SILENCE | 3001 Leuven |
| Formac Pharmaceuticals | 3001 Leuven |
| FOCUS PHARMA | 3001 Leuven |
| Perseus Biomics | 3001 Leuven |
| Raya Therapeutic | 3001 Leuven |
| RheADC | 3001 Leuven |
| COULTREON BIOPHARMA | 3001 Leuven |
| Open Alzheimer | 3001 Leuven |
Frequently asked questions
Is Pledge Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists Pledge Therapeutics as active.
What is the VAT number of Pledge Therapeutics? The VAT number of Pledge Therapeutics is BE 0726.743.301.
When was Pledge Therapeutics founded? Pledge Therapeutics was founded on 14-05-2019.
What is the address of Pledge Therapeutics? The current registered office of Pledge Therapeutics is Gaston Geenslaan 1, 3001 Louvain.
When did Pledge Therapeutics last file annual accounts? The latest annual accounts of Pledge Therapeutics were filed on 15-10-2026.
Does Pledge Therapeutics file its annual accounts on time? Pledge Therapeutics filed its annual accounts within the legal deadline for 0 of its last 4 financial years. Late: 2022, 2023, 2024, 2025.
How many employees does Pledge Therapeutics have? Pledge Therapeutics employs 6.6 full-time equivalents according to its most recent annual accounts.
Is Pledge Therapeutics financially healthy? Addrly gives Pledge Therapeutics a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Pledge Therapeutics profitable? The annual accounts of Pledge Therapeutics for 2025 show a loss of € 1 400 905.
What is the equity of Pledge Therapeutics? The equity of Pledge Therapeutics was € -3 797 155 at the close of the 2025 financial year.
Who are the directors of Pledge Therapeutics? The annual accounts of Pledge Therapeutics record 3 mandates. The names, roles and dates are visible with a free account.
Can Pledge Therapeutics receive Peppol e-invoices? Yes. Pledge Therapeutics is registered on the Peppol network and can receive structured electronic invoices.
What does Pledge Therapeutics do? The main activity of Pledge Therapeutics is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.